Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Tucunduva, L; Ruggeri, A; Sanz, G; Furst, S; Cornelissen, J; Linkesch, W; Mannone, L; Ribera, JM; Veelken, H; Yakoub-Agha, I; González Valentín, ME; Schots, R; Arcese, W; Montesinos, P; Labopin, M; Gluckman, E; Mohty, M; Rocha, V.
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.
Br J Haematol. 2014; 166(5):749-757 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Linkesch Werner

Dimensions Citations:

Plum Analytics:
The status of umbilical cord blood transplantation (UCBT) in adults with Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL) and the impact of minimal residual disease (MRD) before transplant are not well established. We analysed 98 patients receiving UCBT for Ph+ALL in first (CR1) or second (CR2) complete remission (CR1, n = 79; CR2, n = 19) with MRD available before UCBT (92% analysed by reverse transcription polymerase chain reaction). Median age was 38 years and median follow-up was 36 months; 63% of patients received myeloablative conditioning and 42% received double-unit UCBT. Eighty-three patients were treated with at least one tyrosine kinase inhibitor before UCBT. MRD was negative (-) in 39 and positive (+) in 59 patients. Three-year cumulative incidence of relapse was 34%; 45% in MRD+ and 16% in MRD- patients (P =0·013). Three-year cumulative incidence of non-relapse mortality was 31%; it was increased in patients older than 35 years (P = 0·02). Leukaemia-free survival (LFS) at 3 years was 36%; 27% in MRD+ and 49% in MRD- patients (P = 0·05), and 41% for CR1 and 14% for CR2 (P = 0·008). Multivariate analysis identified only CR1 as being associated with improved LFS. In conclusion, MRD+ before UCBT is associated with increased relapse. Strategies to decrease relapse in UCBT recipients with Ph+ALL and MRD+ are needed. © 2014 John Wiley & Sons Ltd.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Aged -
Cord Blood Stem Cell Transplantation - adverse effects
Cord Blood Stem Cell Transplantation - methods
Disease-Free Survival -
Disease-Free Survival -
Female -
Humans -
Male -
Middle Aged -
Neoplasm, Residual -
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Treatment Outcome -
Young Adult -

Find related publications in this database (Keywords)
cord blood transplantation
acute lymphoblastic leukaemia
minimal residual disease
© Meduni Graz Impressum